Reshaping Graves Disease Landscape with DLI's Clinical Trial Management, Regulatory Consulting, Price Reimbursement, and Pharma Consulting Services | Disease Landscape Insights



LONDON, Oct. 9, 2023 /PRNewswire/ — Graves’ Disease (GD) is a rare autoimmune disorder which primarily affects women. According to an epidemiology study, the risk of developing GD is 3% for women and 0.5% for men. Given its rare nature, researchers are yet to find a permanent cure for…

Leave a Reply